Cargando…
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
SIMPLE SUMMARY: We present eight core attributes of cancer growth that we must address for a more effective treatment than we currently have. To do this we outline why a regimen simultaneously using many different drugs will be needed. At our current state of knowledge, even adding two or three drug...
Autores principales: | Kast, Richard E., Alfieri, Alex, Assi, Hazem I., Burns, Terry C., Elyamany, Ashraf M., Gonzalez-Cao, Maria, Karpel-Massler, Georg, Marosi, Christine, Salacz, Michael E., Sardi, Iacopo, Van Vlierberghe, Pieter, Zaghloul, Mohamed S., Halatsch, Marc-Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140192/ https://www.ncbi.nlm.nih.gov/pubmed/35626167 http://dx.doi.org/10.3390/cancers14102563 |
Ejemplares similares
-
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen
por: Salacz, Michael E, et al.
Publicado: (2016) -
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017) -
A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen
por: Kast, Richard E., et al.
Publicado: (2020) -
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen
por: Kast, Richard E., et al.
Publicado: (2018) -
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
por: Kast, Richard E., et al.
Publicado: (2014)